NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/01/2024
Back to search
Official data from USPTO
DERMACYTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
02/01/2024
Trademark type
Word
Nice classes
5
Filing date
11/21/2017
Registration date
07/03/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/01/2024
Last transaction
02/01/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
11/08/2017
First use in commerce
11/08/2017
Drawing code
4
Owner type
03
Owner location
RESEARCH TRIANGLE PARK, NC, US
Examiner
SMITH, BRIDGETT G
Law office
M60
Current location
TMO LAW OFFICE 115
Holders and representatives
Holders
MERAKRIS THERAPEUTICS, INC.
Merakris Therapeutics, LLC
Representatives
Karen M. Hahn HAHN LAW FIRM
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Human biological amniotic membrane tissue intended for subsequent implantation; human biological amniotic tissue derived from postpartum tissues that may include amniotic membraneamniotic fluidumbilical cordplacentaintended for medical use for the treatment of woundsulcersburnsscars and surgical incisions; human biological tissuebloodstem cellsumbilical cords and placentas for use in biological tissue grafts for use in surgery and wound repair; topical treatment in the nature of an allograft for medical use for the treatment of woundsulcersburnsscars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of woundsulcersburnsscars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of woundsulcersburnsscars and surgical incisions; wound treatment in the nature of amniotic material prepared in sheet forms or flowable forms
Publications
History of USPTO decisions and trademark events.
14 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/01/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/01/2024
E815
TEAS SECTION 8 & 15 RECEIVED
08/10/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/03/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/25/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/03/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/17/2018
PUBO
PUBLISHED FOR OPPOSITION
04/17/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/28/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/14/2018
DOCK
ASSIGNED TO EXAMINER
03/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/04/2017
NWAP
NEW APPLICATION ENTERED
11/24/2017
Continuous trademark protection
Get notified about every new filing that threatens DERMACYTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.